SCHEMBL6281698

SCHEMBL6281698

C#CC[C@H](C[C@@H](C=C)O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6284355 1.00
SCHEMBL5546804 0.81
SCHEMBL31376763 0.81
SCHEMBL6286662 0.81
SCHEMBL1472688 0.81
SCHEMBL25316458 0.81
SCHEMBL9413595 0.71
SCHEMBL9812132 0.69
SCHEMBL25891770 0.68
SCHEMBL26756668 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6960573-B2 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same TEIJIN LIMITED (JP) 2005-11-01 US disclosed
US-6867313-B2 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same TEIJIN LIMITED (JP) 2005-03-15 US disclosed
US-6689766-B2 ALSO FOR TREATING MALIGNANT TUMORS, RHEUMATOID ARTHRITIS, OSTEOPOROSIS, DIABETES MELLITUS, HYPERTENSION, ALOPECIA, ACNE, PSORIASIS, DERMATITIS, HYPERCALCEMIA, HYPOPARATHYROIDISM AND METABOLIC DISORDER OF CARTILAGE. TEIJIN LIMITED (JP) 2004-02-10 US disclosed
US-6548489-B2 Also for treating malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage. TEIJIN LIMITED (JP) 2003-04-15 US disclosed
US-6531460-B1 Vitamin D3 derivatives TEIJIN LIMITED (JP) 2003-03-11 US disclosed
US-20020132799-A1 Vitamin D3 dervative and treating agent for inflammatory respiratory disease using same TEIJIN LIMITED 2002-09-19 US disclosed
US-20020103173-A1 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same TEIJIN LIMITED 2002-08-01 US disclosed
US-20020099039-A1 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same TEIJIN LIMITED 2002-07-25 US disclosed
US-20020091109-A1 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same TEIJIN LIMITED 2002-07-11 US disclosed
EP-0854139-B1 Vitamin D3 derivative and production process thereof TEIJIN LTD (JP) 2001-09-05 EP disclosed
EP-1123921-A1 VITAMIN D 3? DERIVATIVES AND REMEDIES FOR INFLAMMATORY RESPIRATORY DISEASES CONTAINING THE SAME TEIJIN LIMITED (JP) 2001-08-16 EP disclosed
EP-0854138-B1 Vitamin D3 derivative and production process thereof TEIJIN LTD (JP) 2001-05-23 EP disclosed
US-6177586-B1 USEFUL AS A PHARMACEUTICAL SUCH AS AN AGENT FOR PROMOTING BONE FORMATION, AN AGENT FOR SUPPRESSING PROLIFERATION OF TUMOR CELLS, AN AGENT FOR HIGH CALCIUM BLOOD DISEASES, AND AN IMMUNOSUPPRESSION AGENT TEIJIN LIMITED (JP) 2001-01-23 US disclosed
EP-0712843-B1 VITAMIN D3 DERIVATIVE AND PROCESS FOR PRODUCING THE SAME TEIJIN LTD (JP) 1999-11-17 EP disclosed
US-5986112-A STEROID DERIVATIVES AS ANTITUMOR AGENTS AND BLOOD METAL CONCENTRATES TEIJIN LIMITED (JP) 1999-11-16 US disclosed
EP-0854138-A2 Vitamin D3 derivative and production process thereof TEIJIN LIMITED (JP) 1998-07-22 EP disclosed
EP-0854139-A2 Vitamin D3 derivative and production process thereof TEIJIN LIMITED (JP) 1998-07-22 EP disclosed
US-5719297-A Vitamin D3 derivatives and production process thereof TEIJIN LIMITED (JP) 1998-02-17 US disclosed
EP-0712843-A1 VITAMIN D3 DERIVATIVE AND PROCESS FOR PRODUCING THE SAME TEIJIN LIMITED (JP) 1996-05-22 EP disclosed